sulfinpyrazone has been researched along with Vascular Diseases in 7 studies
Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
Vascular Diseases: Pathological processes involving any of the BLOOD VESSELS in the cardiac or peripheral circulation. They include diseases of ARTERIES; VEINS; and rest of the vasculature system in the body.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The average racemic plasma warfarin concentration over a dosage interval when adjusted for warfarin dose was not altered by sulphinpyrazone administration." | 1.26 | Interaction of sulphinpyrazone with warfarin. ( Birkett, DJ; Foenander, T; Gallus, AS; Miners, JO; Wanwimolruk, S, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Webster, J | 1 |
| Strobl-Jäger, E | 1 |
| Kaliman, J | 1 |
| Sinzinger, H | 1 |
| Poliwoda, H | 1 |
| Miners, JO | 1 |
| Foenander, T | 1 |
| Wanwimolruk, S | 1 |
| Gallus, AS | 1 |
| Birkett, DJ | 1 |
| Blakely, JA | 1 |
| Harker, LA | 2 |
| Hirsh, J | 1 |
| Gent, M | 1 |
| Genton, E | 1 |
2 reviews available for sulfinpyrazone and Vascular Diseases
| Article | Year |
|---|---|
Critical evaluation of platelet-inhibiting drugs in thrombotic disease.
Topics: Arteriosclerosis; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clo | 1975 |
Antiplatelet drugs in the management of patients with thrombotic disorders.
Topics: Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Blood Coagulation Disorders; Blood Platelets | 1986 |
2 trials available for sulfinpyrazone and Vascular Diseases
| Article | Year |
|---|---|
Plasma factor and platelet sensitivity to prostacyclin in patients with peripheral vascular disease before and after treatment with a combination of a cyclooxygenase and a phosphodiesterase inhibitor.
Topics: Aspirin; Blood Platelets; Clinical Trials as Topic; Cyclooxygenase Inhibitors; Dipyridamole; Drug Th | 1984 |
Critical evaluation of platelet-inhibiting drugs in thrombotic disease.
Topics: Arteriosclerosis; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clo | 1975 |
4 other studies available for sulfinpyrazone and Vascular Diseases
| Article | Year |
|---|---|
Antiplatelet drugs.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Coronary Disease; Dextrans; Dipyridamole; Epopr | 1983 |
[Present situation of therapy with platelet aggregation inhibitors].
Topics: Adult; Aged; Anticoagulants; Aspirin; Cerebrovascular Disorders; Dipyridamole; Humans; Middle Aged; | 1982 |
Interaction of sulphinpyrazone with warfarin.
Topics: Aged; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Protein Bindi | 1982 |
Platelet suppressing drugs in arterial disease.
Topics: Anticoagulants; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clofibrate; Humans; Myocardial | 1978 |